Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Reuters

13:42 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Reuters" found in our extensive news archives from over 250 global news sources.

More Information about Reuters on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reuters for you to read. Along with our medical data and news we also list Reuters Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reuters Companies for you to search.

Showing News Articles 1–25 of 2,600+ from Reuters

Friday 20th July 2018

Cigarette use declines among U.S. young women, but marijuana blunt use rises

(Reuters Health) - Cigarette use decreased among young women - including pregnant women - during the past decade in the U.S., according to a new study. But, researchers found, use of marijuana blunts rose.

CPR training should change, and maybe there should be an app for that

(Reuters Health) - To help more patients survive cardiac arrest, traditional CPR training needs an overhaul with more chances for practice - and instructions on social and digital platforms might help lessons stick, some doctors argue.

'Invisible' stool blood tied to increased risk of premature death

(Reuters Health) - A screening test for colon cancer that looks for "invisible" blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests.

U.S. court rejects Allergan bid to shield patents through tribe deal

A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe.

Bayer to phase out Essure birth control device in U.S.

Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device which made the business no longer sustainable.

FDA approves Agios Pharmaceuticals leukemia drug

Agios Pharmaceuticals Inc said on Friday its oral drug to treat a type of leukemia was approved by the U.S. health regulator.

Virtual reality may help cure fear of heights

(Reuters Health) - A virtual reality program may work at least as well as one-on-one therapy to help people overcome a fear of heights, a UK study suggests.

Swiss, German drugmakers join U.S. price freeze

Roche, Bayer and Germany's Merck KGaA became the latest drug companies to freeze prices in the United States, amid increased scrutiny by the Trump administration of medicine costs.

EU drug regulators step up work to prepare for 'no deal' Brexit

Drug regulators across Europe are hiring extra staff and increasing their workload as the role of British experts in the EU-wide system of medicines supervision winds down ahead of Brexit.

Agios Pharmaceuticals leukemia drug gets U.S. approval

Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.

Bayer to phase out Essure birth control device in U.S

Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device which made the business no longer sustainable.

Honduras appeals WTO landmark ruling on Australia's plain tobacco packaging

Honduras has appealed against a WTO ruling won last month by Australia on its "plain" packaging requirements for tobacco, a WTO spokesman said on Friday.

Roche gets breakthrough status for Alzheimer's test Elecsys

The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday.

Thursday 19th July 2018

Police killings tied to worse mental health for African-Americans

(Reuters Health) - Police killings of unarmed black people are associated with worse mental health for African-Americans across the country, even when they have no direct connection to the deaths, a U.S. study suggests.

Merck lowers prices of some drugs after Trump calls out industry

Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a little-used hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for con...

A tenth of U.S. veteran coal miners have black lung disease: NIOSH

More than 10 percent of America’s coal miners with 25 or more years of experience have black lung disease, the highest rate recorded in roughly two decades, according to a government study released on Thursday that showed cases concentrated heavily...

Brazil's 'Dr. Butt' plastic surgeon arrested after patient death: police

A plastic surgeon known as "Dr. Bumbum" or "Dr. Butt" on social media because of his buttock-enhancement operations was arrested on Thursday in Rio de Janeiro, four days after one of his patients died, police said.

Systemic changes may reduce gender disparities in medical training

(Reuters Health) - Gender disparities in medical careers - in position, pay and publishing - start early, but even small systemic changes in training programs could begin to narrow these gaps, says a group of Harvard Medical School doctors.

Parents' childhood trauma tied to behavior problems in kids

(Reuters Health) - Parents who had a lot of traumatic or stressful experiences during childhood may be more likely to have kids with behavioral problems, a U.S. study suggests.

Mixing alcohol and drugs poses bigger unsafe sex risk for women

(Reuters Health) - Drinking alcohol and smoking pot at the same time is more likely to increase the odds of unsafe sex for young women than for men, a small U.S. study suggests.

More U.S. teens saying 'no' to smoking and drinking

(Reuters Health) - High school students in the U.S. are a lot more sober than they used to be, a new study suggests.

Trump administration proposes altering rule on drug rebates

The Trump administration has proposed a rule that would scale back protections currently in place that allow rebates between drug manufacturers and insurers and pharmacy benefits managers, according to the Office of Management and Budget (OMB) websit...

Chinese pharma firm recalls heart drug in U.S. after possible impurity

The Chinese bulk manufacturer of the common blood and heart drug valsartan said it was recalling the product from consumers in the United States and would halt supplies to the country, after an impurity linked to cancer had been detected.

Allergan, Molecular Partners eye drug meets main goal in two studies

Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies.

Mersana Therapeutics cancer drug trial on partial hold by FDA

Mersana Therapeutics said on Thursday its early-stage trial for its cancer drug has been put on partial hold by the U.S. health regulator after a patient's death was possibly related to the treatment.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks